Guj. Inject(Ker) — 360° view

Guj. Inject(Ker), a company in the Pharmaceuticals industry, reported revenue of ₹5.82 crore and net profit of ₹0.73 crore for the September 2026 quarter.

Guj. Inject(Ker) (BSE: GUJINJEC) closed at ₹10.45 on 20 Nov 2026, up 301.9% over the past year. Its market capitalisation is ₹153 crore and it trades at 41.8 times earnings.

Share price
₹10.45 (20 Nov 2026)
Market cap
₹153 Cr (20 Nov 2026)
P/E
41.83 (20 Nov 2026)
Revenue
₹6 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
22.9% (FY26)
ROE
16.6% (FY26)
Book value
₹0.91 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹14.30 / ₹2.65 (20 Nov 2026)
1-year return
301.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: GUJINJEC

Gujarat Inject (Kerala) Ltd has discontinued its legacy pharmaceutical manufacturing operations and currently follows a trading -led business model transitioning towards renewable energy. Its disclosed activities include supplying 600–620Wp solar-PV modules, investing in a 5MW solar project and evaluating thermal-energy-storage opportunities.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.